Hospital
Lakeland Community Hospital, INC.
Lakeland Community Hospital, INC. was paid $1.13M by Medicaid between Jan 2018 and Dec 2024, across 36 billing codes. Its largest line is 87633, Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets — 52% of everything it billed.
33Billing provider infoLAKELAND COMMUNITY HOSPITAL, INC.
HALEYVILLE, AL 35565
HALEYVILLE, AL 35565
33aNPI1275600967assigned 11/29/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.13M
24GClaims19,429
24DCodes billed36
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Alabama
Rank by total paid#39 of 77
Median peer was paid$1.13M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,361 | $67K | |
| 2019 | 1,899 | $47K | |
| 2020 | 1,772 | $29K | |
| 2021 | 3,288 | $195K | |
| 2022 | 4,401 | $300K | |
| 2023 | 3,280 | $275K | |
| 2024incomplete | 2,428 | $216K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 52% | 2,489 | 2,372 | $592K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 6,427 | 6,093 | $250K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 2,530 | 2,423 | $175K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.0% | 1,953 | 1,873 | $33K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.4% | 310 | 294 | $16K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 305 | 255 | $10K |
| 87070 | <1% | 660 | 637 | $9K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 457 | 427 | $6K |
| 83655 | <1% | 310 | 299 | $6K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 751 | 693 | $6K |
| 80053 | Comprehensive metabolic panel | <1% | 616 | 568 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 393 | 383 | $5K |
24 more codes
| 0002A | <1% | 71 | $3K | |
| 0001A | <1% | 71 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 43 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 87 | $2K |
| 87430 | <1% | 107 | $2K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 22 | $1K |
| 85014 | <1% | 227 | $907.00 | |
| 87088 | <1% | 13 | $214.25 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 17 | $161.10 |
| 81001 | <1% | 44 | $145.10 | |
| 71045 | Radiologic examination, chest; single view | <1% | 25 | $140.36 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 74 | $112.42 |
| 81025 | <1% | 12 | $58.44 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 15 | $43.80 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 12 | $18.90 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 32 | $14.40 |
| 80305 | 0% | 393 | $0.00 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 29 | $0.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 21 | $0.00 |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 446 | $0.00 |
| 99213 | Doctor's office visit, returning patient (routine) | 0% | 384 | $0.00 |
| 99308 | Subsequent nursing facility care, per day, straightforward | 0% | 16 | $0.00 |
| A9270 | Non-covered item or service | 0% | 48 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSIBLEY, CHERIE (CHIEF EXECUTIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Lakeland Community Hospital, INC. | Haleyville, AL | $2.85M |
| Lakeland Community Hospital, INC. | Haleyville, AL | $1.66M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.